z-logo
open-access-imgOpen Access
Status of CHEK2 and p53 in patients with early‑onset and conventional gastric cancer
Author(s) -
Julita Machlowska,
Przemysław Kapusta,
Małgorzata Szlendak,
Anna Bogdali,
Folkert H.M. Morsink,
Paweł Wołkow,
Ryszard Maciejewski,
G.J.A. Offerhaus,
Robert Sitarz
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12609
Subject(s) - chek2 , biology , cancer , cell cycle , dna damage , oncogene , single nucleotide polymorphism , gene , genetics , molecular medicine , cancer research , microbiology and biotechnology , mutation , dna , genotype , germline mutation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom